Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic

The Korean College of Rheumatology Working Group

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Patients with systemic rheumatic diseases (SRD) are vulnerable for coronavirus disease (COVID-19). The Korean College of Rheumatology recognized the urgent need to develop recommendations for rheumatologists and other physicians to manage patients with SRD during the COVID-19 pandemic. The working group was organized and was responsible for selecting key health questions, searching and reviewing the available literature, and formulating statements. The appropriateness of the statements was evaluated by voting panels using the modified Delphi method. Four general principles and thirteen individual recommendations were finalized through expert consensus based on the available evidence. The recommendations included preventive measures against COVID-19, medicinal treatment for stable or active SRD patients without COVID-19, medicinal treatment for SRD patients with COVID-19, and patient evaluation and monitoring. Medicinal treatments were categorized according to the status with respect to both COVID-19 and SRD. These recommendations should serve as a reference for individualized treatment for patients with SRD. As new evidence is emerging, an immediate update will be required.

Original languageEnglish
Pages (from-to)1317-1332
Number of pages16
JournalKorean Journal of Internal Medicine
Issue number6
StatePublished - 2020

Bibliographical note

Publisher Copyright:
© 2020 The Korean Association of Internal Medicine.


  • Coronavirus
  • Recommendations
  • Rheumatic diseases
  • SARS-CoV-2
  • Treatment


Dive into the research topics of 'Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic'. Together they form a unique fingerprint.

Cite this